Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Longeveron Inc (LGVN)

7.07   0.37 (5.52%) 01-26 00:25
Open: 6.48 Pre. Close: 6.7
High: 8.0599 Low: 6.48
Volume: 1,223,937 Market Cap: 147M
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.074 - 8.112 8.112 - 8.147
Low: 6.401 - 6.438 6.438 - 6.472
Close: 7.004 - 7.07 7.07 - 7.129

Technical analysis

as of: 2022-01-25 4:25:23 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 16.40     One year: 22.48
Support: Support1: 5.62    Support2: 4.68
Resistance: Resistance1: 14.04    Resistance2: 19.25
Pivot: 8.89
Moving Average: MA(5): 7.02     MA(20): 9.71
MA(100): 9.37     MA(250):
MACD: MACD(12,26): -2.13     Signal(9): -1.95
Stochastic oscillator: %K(14,3): 9.52     %D(3): 4.92
RSI: RSI(14): 34.65
52-week: High: 45.00  Low: 2.84  Change(%): -4.6
Average Vol(K): 3-Month: 15206  10-Days: 700

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
LGVN has closed above bottom band by 21.6%. Bollinger Bands are 38.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 25 Jan 2022
Longeveron to Participate in Phacilitate Advanced Therapies Week - Yahoo Finance

Thu, 13 Jan 2022
Is it Time to Dump Longeveron Inc (LGVN) Stock After it Has Fallen 5.70% in a Week? - InvestorsObserver

Wed, 12 Jan 2022
Longeveron Announces Publication of Lomecel-B Phase 2b Trial Design in Journal of Frailty and Aging - GlobeNewswire

Mon, 10 Jan 2022
Longeveron Issues Slides For Phase 2a Alzheimer's Study - Benzinga

Wed, 05 Jan 2022
EXCLUSIVE: Longeveron Says 'The Phase 2a Trial Is Designed To Measure Brain Anatomy Using MRI, And Include Detailed Assessments Of The Inflammatory And Vascular Systems Thought To Contribute To The Worsening Of Alzhaimer's Diseas - Benzinga

Thu, 18 Nov 2021
Longeveron Inc. (LGVN) Stock Price, News, Quote, Chart & Historical Prices - Stocks Telegraph

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 5
Shares Float (M) 4
% Held by Insiders 20.35
% Held by Institutions 9.49
Shares Short (K) 821
Shares Short P. Month (K) 1,240

Stock Financials

EPS -0.750
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 1.170
Profit Margin
Operating Margin -650.15
Return on Assets (ttm) -50.1
Return on Equity (ttm) -111.8
Qtrly Rev. Growth -87.6
Gross Profit (p.s.) 0.355
Sales Per Share 0.443
EBITDA (p.s.) -2.705
Qtrly Earnings Growth
Operating Cash Flow (M) -9
Levered Free Cash Flow (M) -3

Stock Valuations

PE Ratio -9.43
PEG Ratio
Price to Book value 6.04
Price to Sales 15.97
Price to Cash Flow

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.